0001140361-23-021501.txt : 20230428
0001140361-23-021501.hdr.sgml : 20230428
20230428160439
ACCESSION NUMBER: 0001140361-23-021501
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230427
FILED AS OF DATE: 20230428
DATE AS OF CHANGE: 20230428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZERBE ROBERT L MD
CENTRAL INDEX KEY: 0001220363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 23865828
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
form4.xml
X0407
4
2023-04-27
0000887359
Vericel Corp
VCEL
0001220363
ZERBE ROBERT L MD
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
false
Common Stock
2023-04-27
4
M
0
2600
A
37395
D
Restricted Stock Unit
2023-04-27
4
M
0
2600
0
D
Common Stock
2600
0
D
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 27, 2022.
Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022.
No expiration date for this type of award.
/s/ Sean Flynn, as Attorney-in-Fact for Robert Zerbe
2023-04-28